IMFINZI-subQ
AstraZeneca
AstraZeneca
National Institutes of Health Clinical Center (CC)
Zymeworks BC Inc.
Nammi Therapeutics Inc
OncoC4, Inc.
Sotio Biotech Inc.
Aptamer Sciences, Inc.
National Cancer Institute (NCI)
Exelixis
ViroMissile, Inc.
Seagen Inc.
MacroGenics
Hefei TG ImmunoPharma Co., Ltd.
City of Hope Medical Center
Jiangsu Simcere Pharmaceutical Co., Ltd.
Degron Therapeutics Co.
NeoTX Therapeutics Ltd.
West China Hospital
Coherus Oncology, Inc.
Pfizer
GONGCHU Biotechnology Co., Ltd
Exelixis
Jonsson Comprehensive Cancer Center
University of Virginia
Incyte Corporation
Incyte Corporation
HC Biopharma Inc.
Coherus Oncology, Inc.
Bristol-Myers Squibb
Sichuan University
Carisma Therapeutics Inc
Vincerx Pharma, Inc.
Molecular Templates, Inc.
National Cancer Institute (NCI)
Xencor, Inc.
Second Affiliated Hospital of Guangzhou Medical University
BioEclipse Therapeutics
Atreca, Inc.
University of Florida
Bayer
Lebanese University
Fate Therapeutics
Tempest Therapeutics
Fate Therapeutics
Xencor, Inc.
Xencor, Inc.
Provectus Pharmaceuticals
Gossamer Bio Inc.
AbbVie
Pfizer